Endometrial cancer is the most common gynaecological tumour in developed countries, and
its incidence is increasing. The most frequently occurring histological subtype is …

Endometrial cancer is the most prevalent gynecologic cancer in the United States. Over the
last 10 years, death rates from endometrial cancer have been rising about 1.4% per year …

The remit of this guideline is to collate and propose evidence-based guidelines for the
diagnosis and management of uterine cancer. This document covers all uterine cancers of …

BGCS uterine cancer guidelines: Recommendations for practice - ScienceDirect Skip to
main contentSkip to article Elsevier logo Journals & Books Search RegisterSign in View …

Predicting distant recurrence of endometrial cancer (EC) is crucial for personalized adjuvant
treatment. The current gold standard of combined pathological and molecular profiling is …

Endometrial cancer is the most common malignancy of the female genital tract in the world
and the seventh most common cause of death from cancer in women in western Europe …

Background Approximately 13% of women diagnosed with endometrial cancer present with
advanced stage disease (International Federation of Gynecology and Obstetrics (FIGO) …

Background: To compare the accuracy of five major risk stratification systems (RSS) in
classifying the risk of recurrence and nodal metastases in early-stage endometrial cancer …

Level I evidence exists for use of adjuvant chemotherapy in stage IIIC endometrial cancer
(positive lymph nodes), although results of randomized trials have varied. Chemotherapy is …

Background Endometrial adenocarcinoma (womb cancer) is a malignant growth of the lining
(endometrium) of the womb (uterus). It is distinct from sarcomas (tumours of the uterine …